SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-042695
Filing Date
2021-08-09
Accepted
2021-08-09 16:35:44
Documents
15
Period of Report
2021-08-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K txmd-8k_20210803.htm   iXBRL 8-K 47371
2 EX-10.1 txmd-ex101_6.htm EX-10.1 241385
3 EX-99.1 txmd-ex991_7.htm EX-99.1 18030
4 GRAPHIC g0vre5ti4voy000001.jpg GRAPHIC 6973
  Complete submission text file 0001564590-21-042695.txt   502513

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA txmd-20210803.xsd EX-101.SCH 5953
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20210803_lab.xml EX-101.LAB 19740
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20210803_pre.xml EX-101.PRE 12279
8 EXTRACTED XBRL INSTANCE DOCUMENT txmd-8k_20210803_htm.xml XML 3547
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 211157028
SIC: 2834 Pharmaceutical Preparations